Enhancement of HPV therapeutic peptide-based vaccine efficacy through combination therapies and improved delivery strategies: A review
Human papillomavirus (HPV) has been linked to the development of various cancers, including head and neck, cervical, vaginal, penile, and anal cancers. The development of therapeutic vaccines against HPV-positive tumors is crucial for protecting individuals already infected with HPV, preventing tumo...
Saved in:
Main Authors: | Rongyu Liu (Author), Xinlin He (Author), Wanying Bao (Author), Zhengyu Li (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2024-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Positive clinical outcomes following therapy with programmed cell death protein 1/programmed cell death ligand 1 inhibitors in neuroendocrine carcinoma of the cervix
by: Rongyu Liu, et al.
Published: (2022) -
Cancer vaccines: Enhanced immunogenic modulation through therapeutic combinations
by: Margaret E. Gatti-Mays, et al.
Published: (2017) -
Enhanced therapeutic efficacy of Listeria-based cancer vaccine with codon-optimized HPV16 E7
by: Feifei Duan, et al.
Published: (2021) -
Primary Care and Community-Based Partnerships to Enhance HPV Vaccine Delivery
by: Patricia A. Carney PhD, MS, et al.
Published: (2024) -
Enhanced Skin Delivery of Therapeutic Peptides Using Spicule-Based Topical Delivery Systems
by: Chi Zhang, et al.
Published: (2021)